Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC
Jakob, M.; Sharaf, K.; Schirmer, M. ; Leu, M.; Küffer, S. ; Bertlich, M. & Ihler, F. et al. (2020)
Strahlentherapie und Onkologie, 197(3) pp. 231-245. DOI: https://doi.org/10.1007/s00066-020-01653-5
